BusinessAXIM® Biotechnologies, Inc. Secures Funding to Continue Pharmaceutical Clinical Trials Program in Cannabinoid Research and Development for Multiple IndicationsBy Nasdaq OMXOct 26, 2016, 1:04 PM UTC
BusinessAXIM Biotechnologies, Inc. CEO to Speak on Emerging Markets and Cannabis Drug Market at Money Show DallasBy Nasdaq OMXOct 19, 2016, 1:02 PM UTC
BusinessAXIM Biotechnologies, Inc. CEO to Speak on Emerging Markets and Cannabis Drug Market at Money Show DallasBy Nasdaq OMXOct 19, 2016, 1:02 PM UTC
BusinessAXIM Biotechnologies, Inc. CEO to Speak at First-Ever National Symposium on Medical Cannabis for Healthcare Professionals in Mexico CityBy Nasdaq OMXOct 6, 2016, 1:00 PM UTC
